Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K091287
    Device Name
    VS-SENSE TEST
    Manufacturer
    Date Cleared
    2009-08-31

    (122 days)

    Product Code
    Regulation Number
    862.1550
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    VS-SENSE TEST

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The VS-SENSE™ TEST is a qualitative, visually-read swab for clinicians who wish to evaluate women with vaginal symptoms. The device is a vaginal pH indicator swab intended to be used in conjunction with other clinical examinations, such as the Amsel criteria or the Nugent Gram stain, to aid in determining conditions characterized by elevated vaginal pH, such as bacterial vaginosis.

    Device Description

    The VS-SENSE™ comprises a regular vaginal swab with its tip coated by an indicating polymer. When the indicating tip has been in contact with vaginal secretion, with elevated pH level, the user will observe a blue or green stain on the yellow background of the tip. The stains on the tip are caused by the sensitivity of a proprietary polymer, which coats the tip and contains the traditional indicator - Nitrazine Yellow. The VS-SENSE™ polymer matrix has a specific composition of ingredients that changes color when the pH of the vaginal discharge is greater than 4.7 +0.3/-0.2.

    AI/ML Overview

    Acceptance Criteria and Study for VS-SENSE™

    1. Acceptance Criteria and Reported Device Performance

    The acceptance criteria for the VS-SENSE™ device are implicitly based on demonstrating substantial equivalence to the predicate device, PHEM-CHEK™. The key performance metrics compared are sensitivity and specificity, both as a standalone test and as a second test within the Amsel Criteria procedure.

    CharacteristicAcceptance Criteria (from Predicate PHEM-CHEK™)Reported VS-SENSETM Performance
    Sensitivity (Stand-alone)91%86.3%
    Sensitivity (As 2nd test of the Amsel Criteria procedure)99%97%
    Specificity (Stand-alone)84.2%93.9%
    Specificity (As 2nd test of the Amsel Criteria procedure)43.42%43.5%

    Note: The document states that the VS-SENSETM's performance is "Based on pivotal study results," implying that these reported values represent the device's actual performance in the study and were considered acceptable for substantial equivalence.

    2. Sample Size and Data Provenance for the Test Set

    The document does not explicitly state the sample size used for the test set or the data provenance (e.g., country of origin, retrospective/prospective nature). It only refers to "pivotal study results" when reporting the sensitivity and specificity values.

    3. Number of Experts and Qualifications for Ground Truth

    The document does not specify the number of experts used to establish the ground truth for the test set or their qualifications. However, it mentions that the device is intended to be used in conjunction with "other clinical examinations, such as the Amsel criteria or the Nugent Gram stain," which are often interpreted by trained medical professionals.

    4. Adjudication Method for the Test Set

    The document does not provide information on the adjudication method used for the test set.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    The document does not mention a multi-reader multi-case (MRMC) comparative effectiveness study. The comparison presented is between the standalone performance of the VS-SENSE™ and the predicate device, and their performance as a second test within the Amsel Criteria procedure. There is no information about how much human readers improve with AI vs. without AI assistance, as this device uses a visual indicator and not AI.

    6. Standalone Performance Study

    Yes, a standalone study was done. The document reports "Stand-alone" sensitivity and specificity for the VS-SENSE™ as 86.3% and 93.9% respectively, and for the predicate PHEM-CHEK™ as 91% and 84.2% respectively. This indicates that the algorithm's performance without human-in-the-loop assistance was evaluated. The device itself is a visually-read swab, so "algorithm" here refers to the chemical reaction and visual indication, interpreted by a user.

    7. Type of Ground Truth Used

    The type of ground truth used is implied to be based on an assessment of conditions characterized by elevated vaginal pH, such as bacterial vaginosis, likely diagnosed using established clinical methods like the Amsel criteria or Nugent Gram stain. These methods typically rely on expert interpretation of clinical signs and microscopic findings.

    8. Sample Size for the Training Set

    The document does not provide information about the sample size for the training set.

    9. How Ground Truth for the Training Set Was Established

    The document does not provide information on how the ground truth for the training set was established.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1